Editor-in-Chief & Deputy Editor 2019-2021

 

Editor-in-Chief:

Nicolas LANTHIER

 

Deputy Editor:

Tim VANUYTSEL

 

More news.

 

Symposium: Infections et Gastroentérologie, Société Royale Belge de Gastro-Entérologie (13/06/2009)


Microbes or man, who will win ? (extended summary)


Price: €10,00

Once the cause of infectious diseases had been uncovered, mainly thanks to the work of Robert Koch, Louis Pasteur and their followers at the end of the nineteenth and the beginning of the twentieth century, a multivalent strategy was implemented to prevent and control microbial infections due to bacteria, viruses or parasites. Thanks to hygiene, the control of insect vectors, vaccination and the wide use of antibiotics, the most dangerous and widespread infectious diseases could be more or less controlled, at least in developed countries. Hence the impression, in the 1970s, that the fight against infectious diseases had been won. This was a major mistake. Beginning at the end of the 1970s, several new infectious diseases have emerged, some of them, like AIDS, taking hundreds of thousands or even millions of lives every year. In this presentation, on a few examples, we analyze the causes of this emergence and then review the new actions that are or could be taken to control infectious diseases. [Product Details...]


Prevention of opportunistic infections in patients with inflammatory bowel disease and implications of the ECCO consensus in Belgium


Price: €10,00

In an era of increasing use of immunomodulator (IM) therapy, opportunistic infections have emerged as a pivotal safety issue in patients with inflammatory bowel disease (IBD). Today’s challenge to the physician is not only to manage IBD, but also to recognise, prevent and treat common and uncommon infections. The recent European ECCO guidelines on the management and prevention of opportunistic infections in patients with IBD provide clinicians with guidance on the prevention, detection and management of opportunistic infections in patients with IBD. Proposals may appear radical, potentially changing current practice, but we believe that the recommendations will help optimise patient outcomes by reducing morbidity and mortality related to opportunistic infections in patients with IBD. In this ongoing process, prevention is far the first and most important step. Prevention of opportunistic infections relies on recognition of risk factors for infection, the use of primary or secondary chemoprophylaxis, careful monitoring (clinical and laboratory work-up) before and during the use of immunomodulators, vaccination and education of the patient. Special recommendations should also be given to patients before travel. Additionally, this paper discusses how the ECCO guidelines can be implemented in Belgium according to reimbursement legislation. (Acta gastro enterol. belg., 2010, 73, 41-45). [Product Details...]


  • «« Start
  • « Prev
  • 1
  • Next »
  • End »»
Results 1 - 2 of 2